hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Cancer|Pancreatic Cancer|Head and Neck Cancer|Ovarian Cancer|ColoRectal Cancer|Gastric Cancer|Esophageal Cancer|HepatoCellular Carcinoma
Interventions: BIOLOGICAL: INO-1400|BIOLOGICAL: INO-9012|BIOLOGICAL: INO-1401
Sponsor: Inovio Pharmaceuticals
Collaborators: University of Pennsylvania|University of North Carolina|Thomas Jefferson University|University of Pittsburgh|Barbara Ann Karmanos Cancer Institute|Mayo Clinic